Search company, investor...
LifeBond company logo

LifeBond

life-bond.com

Stage

Acquired | Acquired

Total Raised

$67.5M

About LifeBond

LifeBond is a provider in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body's natural healing process and tissue repair.On January 15th, 2020, LifeBond was acquired by C.R. Bard. Terms of the transaction were not disclosed.

Headquarters Location

P.O.B. 3048

Caesarea, 38900,

Israel

Missing: LifeBond's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: LifeBond's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing LifeBond

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LifeBond is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

LifeBond Patents

LifeBond has filed 1 patent.

The 3 most popular patent topics include:

  • Biomaterials
  • Implants (medicine)
  • Tissue engineering
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/25/2015

2/12/2019

Dosage forms, Polymers, Polymer chemistry, Drug delivery devices, Polysaccharides

Grant

Application Date

4/25/2015

Grant Date

2/12/2019

Title

Related Topics

Dosage forms, Polymers, Polymer chemistry, Drug delivery devices, Polysaccharides

Status

Grant

Latest LifeBond News

Bard buys Israeli hernia mesh co LifeBond

Jan 15, 2020

Bard buys Israeli hernia mesh co LifeBond The US medical device company will pay close to the $60 million that LifeBond has raised from investors. US medical device company Bard has acquired Israeli hernia mesh developer LifeBond for close to the $60 million that the company has raised to date, sources inform "Globes." Bard is a division of Becton Dickinson (BD). Founded in 2007, the main investors in LifeBond have been Pitango and medical device investor Robert Taub, who founded Omrix, which developed similar sealant technology and was sold to Johnson & Johnson for $438 million. Taub invested in LifeBond due to his deep understanding of the sector even though the company's product was likely to be a rival to Omrix. J&J also invested in LifeBond seeing its product as complementary to Omrix's. RELATED ARTICLES Other investors in LifeBond include Adams Street Partners, China's Sino Biopharmaceutical Ltd., Glenrock, Aurum Ventures, Giza, and Zitelman Group. LifeBond was founded by Issay Attar and Orahn Preiss-Bloom. Attar is a medical engineer and entrepreneur who also founded other startups including Biochange and Outsense, and Preiss-Bloom is a biomedical engineer and biomechanical researcher who also founded the medical device startup Ossio. The pair founded the company after the Second Lebanon War in 2006 when they saw the need for technology to stop soldiers bleeding after various injuries. The company developed a product to minimize post-operative complications such as staple-line leakage in GI and bariatric surgeries. In clinical trials LifeBond's first product failed and the company switched its emphasis to a hernia mesh to prevent leakages after hernia surgery. The product is about to enter clinical trials but because the company has regressed in development terms, the size of the exit is less than might have been hoped for. Published by Globes, Israel business news - en.globes.co.il - on January 15, 2020 © Copyright of Globes Publisher Itonut (1983) Ltd. 2020

LifeBond Frequently Asked Questions (FAQ)

  • Where is LifeBond's headquarters?

    LifeBond's headquarters is located at P.O.B. 3048, Caesarea.

  • What is LifeBond's latest funding round?

    LifeBond's latest funding round is Acquired.

  • How much did LifeBond raise?

    LifeBond raised a total of $67.5M.

  • Who are the investors of LifeBond?

    Investors of LifeBond include C.R. Bard, Pitango Venture Capital, Sino Biopharmaceutical, Adams Street Partners, Robert Taub and 7 more.

  • Who are LifeBond's competitors?

    Competitors of LifeBond include Tepha, Paragon Medical, Corpora Systems, VisionCare Ophthalmic Technologies, MAKO Surgical and 12 more.

Compare LifeBond to Competitors

L
L.I.T. Surgical

L.I.T. Surgical (formerly known as Alpha Med-Surge) is a medical device company that has developed a patent-protected, head-mounted surgical headlight that surpasses the current industry standard to meet the critical needs of surgeons throughout the world. The L.I.T. Surgical design aims to deliver a cooler, brighter light through the combination and collection of light from multiple LEDs, and the direction of that light through sophisticated optical geometry. This results in a highly efficient "white light" that aims to enable the user to view the working field and identify structures with unparalleled clarity and definition.

O
Otothera Corporation

Otothera Corporation is a medical device company developing products to diagnose and treat the more than seven million severe tinnitus (constant ringing in the ears) sufferers in the US. The company was originally named AudioFusion. The company was a 2006 PTEN Growth Accelerator (GAP) winner.

V
Verimetra

Verimetra aims to make medical instruments "smart" and manufacturers miniature thin film sensors used in medical applications that involve very small high end catheters. The Company designs and manufactures sensors using micro-electromechanical systems (MEMS) technology, which is the only method available that produces sensors small enough to be embedded in surgical devices without changing their basic form or function, allowing the company's customers to sell the same products, now "smart", without requiring the surgeon to use a new device. Verimetra aims to make medical devices "smart" by embedding (US Patent 6,494,882) a variety of small sensors at an place on or within the device. Simply stated, the company make "dumb" metal tools "smart". Examples include forceps, grippers, retractors, drills, and other surgical devices. Through the use of Verimetra's products, medical device manufacturers are able to deliver features and functionality that, depending on the medical procedure, improve outcomes, reduce risk and shorten patient recovery times. Verimetra's new product features are also used by manufacturers to strengthen their market position, enter new markets and maintain gross margins. Verimetra aims to give these manufacturers a way to accomplish these goals by adding features at a low cost without product redesign. Furthermore, in many instances, Verimetra's customers' goals will be met by the transformation of a re-usable product (one-time sale) into a smart disposable product (one sale per procedure).

B
BioMimetic Systems

BioMimetic Systems (BMS) is developing biologically inspired technologies for advanced sensors and medical devices. BMS has its roots in the Boston University Hearing Research Center and VLSI laboratories with more than 30 years of experience researching the physiology and biophysics of hearing as well as specialized custom electronics. The focus of BMS is the application of biologically inspired algorithms to technically challenging problems that traditional approaches have failed to address. Applications include sensor design for high noise environments as well as medical devices for the hearing impaired.

TheraTogs Logo
TheraTogs

TheraTogs, based in Telluride, Colorado, is a medical device company offering orthotic undergarment and strapping systems that give users with sensorimotor impairment modality for improving postural alignment and stability movement skill and precision and joint stability.

EndoMedix Logo
EndoMedix

Endomedix develops hydrogel technology within the medical device market. At the core of Endomedix's technology is a biocompatible, biodegradable, environmentally-responsive hydrogel with a number of biomedical applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.